Meanwhile, BMO Capital Markets downgraded its Novo Nordisk ADR [NVO] rating to a Market perform from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including Kepler’s analysts, who increased its forecast for the stock in mid March from “a Hold” to “a Buy”. Stifel also remained covering NVO and has decreased its forecast on March 03, 2025 with a “Hold” recommendation from previously “Buy” rating. Morgan Stanley started covering the stock on February 12, 2025. It rated NVO as “an Equal-weight”.
Price Performance Review of NVO
On Monday, Novo Nordisk ADR [NYSE:NVO] saw its stock jump 0.43% to $58.33. Over the last five days, the stock has lost -9.89%. Novo Nordisk ADR shares have fallen nearly -32.19% since the year began. Nevertheless, the stocks have fallen -53.16% over the past one year. While a 52-week high of $148.15 was reached on 02/25/25, a 52-week low of $57.28 was recorded on 04/21/25. SMA at 50 days reached $76.53, while 200 days put it at $105.08.
Levels Of Support And Resistance For NVO Stock
The 24-hour chart illustrates a support level at 57.12, which if violated will result in even more drops to 55.91. On the upside, there is a resistance level at 59.42. A further resistance level may holdings at 60.51. The Relative Strength Index (RSI) on the 14-day chart is 30.83, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -3.95, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 89.77%. Stochastics %K at 7.60% indicates the stock is a buying.
How much short interest is there in Novo Nordisk ADR?
A steep rise in short interest was recorded in Novo Nordisk ADR stocks on 2025-03-31, growing by 1.15 million shares to a total of 14.66 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 13.51 million shares. There was a rise of 7.83%, which implies that there is a positive sentiment for the stock.
